MAPT and neurodegenerative disease: Collectively, our previous and present studies establish abnormal GSK3β activation as an important contributor to mitochondrial defect in diabetic retinal neurodegeneration, not only by triggering hyperphosphorylated tau-induced impairment in synaptic targeting of mitochondria [6], but also by inhibiting β-catenin-regulated oxidative stress resistance.